Alan Gregg | |
---|---|
![]() | |
Born | July 11, 1890 [1] Colorado Springs, Colorado [1] |
Died | June 19, 1957 66) [2] | (aged
Education | Harvard University (A.B. 1911) [1] [3] Harvard University (M.D. 1916) [4] [3] |
Medical career | |
Institutions | Harvard Surgical Unit (Nov. 1917 - Jan. 1919) [3] [5] [6] Rockefeller Foundation (1919-1956) [1] |
Awards | Lasker Award [7] |
Alan Gregg (1890–1957) was an American physician active in the fields of public health, medical education and research. [1] [4] [8] [9] Gregg worked at the Rockefeller Foundation in New York City from 1919 until he retired in 1956, in that time spending 20 years as Director of the Medical Sciences Division and finishing his career as the foundation's vice president. [2] [9] During his career, he helped develop the United States' now predominant model for funding medical research. [9] [10] Rockefeller grants that he championed helped finance the development of sulfanilamide and penicillin, [2] some of the first antibiotic drugs.
In 1940 he gave a Terry Lecture on the topic of medical research. [11] Throughout his career, he declined many honorary degrees and awards because he did not want to be in the position of later giving a grant to an award donor. [2] However, in 1956, after his retirement, he accepted a special Lasker Award that recognized his contributions to medicine. [1] [7] He was a fellow of the American Association for the Advancement of Science, [2] an honorary fellow of the Royal Society of Medicine and received the French Legion of Honor. [4] He was an elected member of both the American Philosophical Society and the American Academy of Arts and Sciences. [12] [13] In 1958, after his death, the American Association of Medical Colleges inaugurated a lecture series named in his honor. [14]
The Rockefeller Foundation is an American private foundation and philanthropic medical research and arts funding organization based at 420 Fifth Avenue, New York City. The second-oldest major philanthropic institution in America, after the Carnegie Corporation, the foundation was ranked as the 39th largest U.S. foundation by total giving as of 2015. By the end of 2016, assets were tallied at $4.1 billion, with annual grants of $173 million. According to the OECD, the foundation provided US$103.8 million for development in 2019. The foundation has given more than $14 billion in current dollars.
Christian Boehmer Anfinsen Jr. was an American biochemist. He shared the 1972 Nobel Prize in Chemistry with Stanford Moore and William Howard Stein for work on ribonuclease, especially concerning the connection between the amino acid sequence and the biologically active conformation.
The Lasker Awards have been awarded annually since 1945 to living persons who have made major contributions to medical science or who have performed public service on behalf of medicine. They are administered by the Lasker Foundation, which was founded by Albert Lasker and his wife Mary Woodard Lasker. The awards are sometimes referred to as "America's Nobels".
Max Theiler was a South African-American virologist and physician. He was awarded the Nobel Prize in Physiology or Medicine in 1951 for developing a vaccine against yellow fever in 1937, becoming the first African-born Nobel laureate.
Mario Ramberg Capecchi is an Italian-born molecular geneticist and a co-awardee of the 2007 Nobel Prize in Physiology or Medicine for discovering a method to create mice in which a specific gene is turned off, known as knockout mice. He shared the prize with Martin Evans and Oliver Smithies. He is currently Distinguished Professor of Human Genetics and Biology at the University of Utah School of Medicine.
Abraham Flexner was an American educator, best known for his role in the 20th century reform of medical and higher education in the United States and Canada.
George F. Koob is a Professor and former Chair of the Committee on the Neurobiology of Addictive Disorders at The Scripps Research Institute and Adjunct Professor of Psychology, Psychiatry, and Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego. In 2014 he became the director of the National Institute on Alcohol Abuse and Alcoholism.
Irvine Heinly Page was an American physiologist who played an important part in the field of hypertension for almost 60 years while working at the Cleveland Clinic as the first Chair of Research.
Carola Blitzman Eisenberg was an Argentine-American psychiatrist who became the first woman to hold the position of Dean of Students at Massachusetts Institute of Technology. From 1978 to 1990, she was the Dean of Student Affairs at Harvard Medical School (HMS). She has for a long time been Lecturer in the newly renamed Department of Global Health and Social Medicine at HMS. She was also both a Founding Member of Physicians for Human Rights and an Honorary Psychiatrist with the Massachusetts General Hospital in Boston, a longstanding position there.
Philippa "Pippa" Marrack, FRS is an English immunologist and academic, based in the United States, best known for her research and discoveries pertaining to T cells. Marrack is the Ida and Cecil Green Professor and chair of the Department of Biomedical Research at National Jewish Health and a distinguished professor of immunology and microbiology at the University of Colorado Denver.
Cato T. Laurencin, M.D., Ph.D., FREng SLMH, is an American engineer, physician, scientist, innovator and a University Professor of the University of Connecticut.
Kevin J. Tracey, a neurosurgeon and inventor, is the president and CEO of the Feinstein Institute for Medical Research, professor of neurosurgery and molecular medicine at Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, and president of the Elmezzi Graduate School of Molecular Medicine in Manhasset, New York. The Public Library of Science Magazine, PLOS Biology, recognized Tracey in 2019 as one of the most cited researchers in the world.
Graham Andrew Colditz MD, DrPH is an Australian chronic disease epidemiologist. He is the inaugural Niess-Gain Professor at Washington University School of Medicine, where he is associate director for Prevention and Control at the Alvin J. Siteman Cancer Center. He directs the Master of Population Health Science at Washington University School of Medicine. During medical training he was excited by the potential for prevention of chronic diseases. With encouragement from mentors he pursued training in the US as it was routine for academics in Australia to obtain overseas training at that time. He is internationally recognized for leadership in cancer prevention, and is often interviewed by media for input on this topic. With members of Cancer Prevention and Control at Siteman, he blogs on issues relating to cancer prevention and screening. According to Google Scholar statistics, Colditz has a h-index of more than 300.
Rita Charon, is a physician, literary scholar and the founder and executive director of the Program in Narrative Medicine at Columbia University. She currently practices as a general internist at the Associates in Internal Medicine at Columbia Presbyterian Hospital, and is a professor of clinical medicine at the College of Physicians and Surgeons of Columbia University.
Carl Ronald Kahn is an American physician and scientist, best known for his work with insulin receptors and insulin resistance in diabetes and obesity. He is the Chief Academic Officer at Joslin Diabetes Center, the Mary K. Iacocca Professor of Medicine at Harvard Medical School and a member of the National Academy of Sciences since 1999.
Reza Dana is the Claes H. Dohlman Professor of Ophthalmology, senior scientist and W. Clement Stone Clinical Research Scholar at Massachusetts Eye and Ear, Harvard Medical School, and director of the Harvard-Vision Clinical Scientist Development Program.
Barry R. Bloom is Harvard University Distinguished Service Professor and Joan L. and Julius H. Jacobson Professor of Public Health in the Department of Immunology and Infectious Diseases and Department of Global Health and Population in the Harvard T.H. Chan School of Public Health in Boston, where he served as dean of the faculty from 1998 through December 31, 2008.
Gregg Leonard Semenza is a Pediatrician and Professor of Genetic Medicine at the Johns Hopkins School of Medicine. He serves as the director of the vascular program at the Institute for Cell Engineering. He is a 2016 recipient of the Albert Lasker Award for Basic Medical Research. He is known for his discovery of HIF-1, which allows cancer cells to adapt to oxygen-poor environments. He shared the 2019 Nobel Prize in Physiology or Medicine for "discoveries of how cells sense and adapt to oxygen availability" with William Kaelin Jr. and Peter J. Ratcliffe.
William G. Kaelin Jr. is an American Nobel laureate physician-scientist. He is a professor of medicine at Harvard University and the Dana–Farber Cancer Institute. His laboratory studies tumor suppressor proteins. In 2016, Kaelin received the Albert Lasker Award for Basic Medical Research and the AACR Princess Takamatsu Award. He also won the Nobel Prize in Physiology or Medicine in 2019 along with Peter J. Ratcliffe and Gregg L. Semenza.
Barry Spencer Coller is an American physician known for his research in platelet physiology and for inventing the Abciximab. He is the David Rockefeller Professor, Physician-In-Chief, and Vice President for Medical Affairs at Rockefeller University.
Named in honor of the late Alan Gregg, American physician, educator, and philanthropist, this lecture was presented for the first time at the 1958 annual meeting of the Association of American Medical Colleges.